Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Alnylam and Dicerna to develop liver disease therapies

pharmaceutical-technologyApril 08, 2020

Tag: Alnylam Pharmaceuticals , Dicerna Pharmaceuticals , Liver Disease , ALN-AAT02

PharmaSources Customer Service